Eli Lilly and Company Associate Vice President – Clinical Research, Oncology Aimee Lin received her PhD in Pharmaceutical Sciences at the University of Kentucky, College of Pharmacy and has over 20 years of clinical research experience in both early and late phase development. (more ...) She has been actively involved in diversity initiatives at Lilly and was an ambassador to Eldoret, Kenya, to support Lilly’s partnership with AMPATH. She currently leads a Phase 3 study in Lung Cancer, which is utilizing biomarker testing across diverse geographies and populations to identify potential patients. HEC member category Industry
